Therapeutic Challenges Following Lung Transplantation
- 1 June 1990
- journal article
- research article
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 11 (2) , 279-290
- https://doi.org/10.1016/s0272-5231(21)00695-x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant RecipientsNew England Journal of Medicine, 1987
- Central Nervous System Toxicity after Liver TransplantationNew England Journal of Medicine, 1987
- VERAPAMIL INHIBITS CYCLOSPORIN METABOLISMThe Lancet, 1987
- EXACERBATION OF CYCLOSPORINE TOXICITY BY CONCOMITANT ADMINISTRATION OF ERYTHROMYCINTransplantation, 1987
- PROFOUND HYPOMAGNESEMIA AND RENAL MAGNESIUM WASTING ASSOCIATED WITH THE USE OF CYCLOSPORINE FOR MARROW TRANSPLANTATIONTransplantation, 1985
- Convulsions associated with cyclosporin A in renal transplant recipients.BMJ, 1985
- CYCLOSPORINE-ASSOCIATED CENTRAL NERVOUS SYSTEM TOXICITY AFTER RENAL TRANSPLANTATIONTransplantation, 1985
- CYCLOSPORINE-ASSOCIATED CENTRAL NERVOUS SYSTEM TOXICITY AFTER ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1984
- CYCLOSPORIN IN CADAVERIC RENAL TRANSPLANTATION: ONE-YEAR FOLLOW-UP OF A MULTICENTRE TRIALThe Lancet, 1983
- HYPERKALAEMIA IN CYCLOSPORIN-TREATED RENAL ALLOGRAFT RECIPIENTSThe Lancet, 1983